Getinge AB (publ) (GETI_B) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Jettinga Q1 Report 2025. During the questions and answers session, participants are able to ask questions by dialing pound key five on their telephone keypad. Now I will hand the conference over to the speakers, CEO Matthias Peerjus and CFO Agneta Palmer. Please go ahead. thank you very much welcome everyone to today's conference today we'll focus on first a quick look into our performance in the first quarter and then reflect a bit on the current market situation and our expectations for 2025. so we can jump directly to page number two please looking then at some of the key takeaways when it comes to the performance from the first quarter we do look back at a solid quarter when it comes to top line our order intake grew by 7.1 percent and it was 2.9 organic growth out of this our net sales increased by 10.7 percent in the quarter where organic growth was 6.2 percent The positive development was primarily attributed to acute care therapists and from a geographic perspective to the Americas. When it comes to the adjusted gross and EBITDA margins, they improved by about one percentage point in the quarter and this was mainly thanks to leverage from volume acquisitions, healthy price increases and positive mix as well. Currency was a headwind and weighed on the EBITDA margin in the quarter. When you look at our financial leverage, it's now back on a similar level to last year in spite of the increase in the debt level after the acquisition of Paragonic. So that means our financial position remains solid. We can then move to page number three, please. So I just wanted to touch briefly on some of the key activities and events during the first quarter of this year. Let's start with sustainability and quality. So securing compliant quality in our products and...